NCT02573623

Brief Summary

Diagnosis of tuberculosis (TB)in young children is a challenge due to atypical non-specific symptoms, difficulty to expectorate mucus, paucibacillary nature of pulmonary TB and low sensitivity of available diagnostic tools. This project aims at evaluating two innovative immunological methods for diagnosing of active TB among HIV-infected and uninfected children.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2013

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2013

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

September 22, 2015

Completed
9 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2015

Completed
11 days until next milestone

First Posted

Study publicly available on registry

October 12, 2015

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

October 12, 2015

Status Verified

October 1, 2015

Enrollment Period

2.3 years

First QC Date

September 22, 2015

Last Update Submit

October 9, 2015

Conditions

Keywords

Immunology diagnosis testChildrenZambia

Outcome Measures

Primary Outcomes (2)

  • Proportion of children with tuberculosis who are correctly identified by a immunoenzymatic test for tuberculosis as having the condition

    baseline

  • Proportion of tuberculosis negative children who are correctly identified as such by a immunoenzymatic test for tuberculosis

    baseline

Study Arms (6)

HIV-infected children with confirmed TB

Hospitalized children with TB confirmed by culture or GeneXpert

HIV-uninfected children aged<5 years with confirmed TB

Hospitalized children aged\<5 years with TB confirmed by culture or GeneXpert

HIV-uninfected children aged>4 years with confirmed TB

Hospitalized children aged\>4 years with TB confirmed by culture or GeneXpert

HIV-infected control children

Children hospitalized in the surgery ward without any evidence of tuberculosis infection

HIV-uninfected controls aged <5 years

Children \<5 years hospitalized in the surgery ward without any evidence of tuberculosis infection

HIV-uninfected controls aged >4 years

Children \>4 years hospitalized in the surgery ward without any evidence of tuberculosis infection

Eligibility Criteria

AgeUp to 15 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Children aged 0 to 15 years with a definite diagnosis of tuberculosis infection, HIV-infected or uninfected. They will be matched on age and HIV status, to an equivalent number of children without any evidence of tuberculosis infection.

You may qualify if:

  • one of 4 clinical signs
  • persistent and unexplained cough
  • unexplained weight loss or failure to thrive
  • persistent and unexplained fever
  • persistent and unexplained lethargy or reduced playfulness
  • chest X-Ray consistent with a tuberculosis infection
  • an adenitis compatible with non-pulmonary tuberculosis Among these children only those with confirmed TB will be analysed for the primary outcome
  • children without any of the signs and symptoms quoted above

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Paediatrics and Child Health, University Teaching Hospital.UNZA-SOM

Lusaka, Zambia

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

Urine Serum Cell culture supernatant

MeSH Terms

Conditions

Tuberculosis

Condition Hierarchy (Ancestors)

Mycobacterium InfectionsActinomycetales InfectionsGram-Positive Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfections

Study Officials

  • Edouard Tuaillon, MD, PhD

    Université de Montpellier, France

    STUDY DIRECTOR
  • Chipepo Kankasa, MD, PhD

    University of Zambia, Zambia

    STUDY DIRECTOR
  • Philippe Van de Perre, MD, PhD

    Université de Montpellier, France

    STUDY CHAIR
  • Nicolas Nagot, MD, PhD

    Université de Montpellier, France

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Chipepo Kandasa, MD, PhD

CONTACT

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 22, 2015

First Posted

October 12, 2015

Study Start

July 1, 2013

Primary Completion

October 1, 2015

Study Completion

December 1, 2015

Last Updated

October 12, 2015

Record last verified: 2015-10

Locations